Moreover, findings from neuropathic pain models—such as improvements in nerve conduction and reductions in pro-inflammatory cytokines (e.g., IL-6, TNF-α, CRP)—lend additional biological plausibility, although the certainty of this evidence remains limited [26,29,54,55,67]. The gene discussed is CRP; the disease is neuropathic pain.